Leprosy disease remains an important public health issue as it is still endemic in several countries. Mycobacterium leprae, the causative agent of leprosy, presents tropism for cells of the reticuloendothelial and peripheral nervous system. Current multidrug therapy consists of clofazimine, dapsone and rifampicin. Despite significant improvements in leprosy treatment, in most programs, successful completion of the therapy is still sub-optimal. Drug resistance has emerged in some countries. This review discusses the status of leprosy disease worldwide, providing information regarding infectious agents, clinical manifestations, diagnosis, actual treatment and future perspectives and strategies on targets for an efficient targeted delivery therapy.
Background:
Tuberculosis is a chronic respiratory disease caused by Mycobacterium
tuberculosis. The common treatment regimens of tuberculosis are lengthy with adverse
side effects, low patient compliance, and antimicrobial resistance. Drug delivery systems
(DDSs) can overcome these limitations.
Objective:
This review aims to summarize the latest DDSs for the treatment of tuberculosis.
In the first section, the main pharmacokinetic and pharmacodynamic challenges posed by
the innate properties of the drugs are put forth. The second section elaborates on the use of
DDS to overcome the disadvantages of the current treatment of tuberculosis.
Conclusion:
We reviewed research articles published in the last 10 years. DDSs can improve
the physicochemical properties of anti-tuberculosis drugs, improving solubility, stability, and
bioavailability, with better control of drug release and can target alveolar macrophages. However,
more pre-clinical studies and robust bio-relevant analyses are needed for DDSs to become
a feasible option to treat patients and attract investors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.